KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) EPS (Weighted Average and Diluted): 2020-2025

Historic EPS (Weighted Average and Diluted) for Adaptive Biotechnologies (ADPT) over the last 5 years, with Sep 2025 value amounting to $0.06.

  • Adaptive Biotechnologies' EPS (Weighted Average and Diluted) rose 127.27% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.53, marking a year-over-year increase of 60.45%. This contributed to the annual value of -$1.08 for FY2024, which is 30.77% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' EPS (Weighted Average and Diluted) is $0.06, which was up 135.29% from -$0.17 recorded in Q2 2025.
  • Adaptive Biotechnologies' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.06 during Q3 2025, with a 5-year trough of -$0.48 in Q4 2023.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.27, with a median of -$0.31 in 2024.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 71.43% in 2023, then spiked by 127.27% in 2025.
  • Over the past 5 years, Adaptive Biotechnologies' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.44 in 2021, then surged by 36.36% to -$0.28 in 2022, then plummeted by 71.43% to -$0.48 in 2023, then skyrocketed by 54.17% to -$0.22 in 2024, then spiked by 127.27% to $0.06 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.06 for Q3 2025, versus -$0.17 for Q2 2025 and -$0.20 for Q1 2025.